Subscribe to RSS

DOI: 10.1055/s-0042-1758160
Heterotopic Ossification in Hip Arthroscopy
Authors
Funding None.
Abstract
Introduction Hip arthroscopy is a rising surgical technique due to the increase in hip diseases, especially femoroacetabular impingement. One of the several complications related to such procedures is heterotopic ossifications (HO). The aim of this study is to describe the prevalence of HO after hip arthroscopy in a series of patients with femoroacetabular impingement and to compare its preoperative and intraoperative variables with a matched control group of patients without HO.
Methods All patients who underwent hip arthroscopy for femoroacetabular impingement between 2010 and 2017 with a minimum follow-up of 2 years were included in this analysis. Radiographic examinations were recorded to select cases with HO. A case-control analysis was performed comparing preoperative and intraoperative variables between cases with HO and a matched control group without HO.
Results A total of 700 cases were included in the analysis. HO was found in 15 (2.14%) of subjects. Cases with HO showed more severe cartilage injuries, less cam morphology ratio, and a higher proportion of partial labrectomies than the control group. No significant differences were observed in preoperative hip pain or function between groups.
Conclusions The prevalence of HO after hip arthroscopy in subjects with femoroacetabular impingement was 2.14%. Cases with HO had more severe cartilage injuries, lower ratio of cam morphology, and higher proportion of partial labrectomies than the control cases without HO.
Level of Evidence Level III.
Heterotopic ossification (HO) is defined as the abnormal bone growth in the nonskeletal soft tissue such as muscle or tendons.[1] Published studies on its incidence in hip arthroscopies highlight important differences in the results. HO has been observed in 0 to 44% of hip arthroscopies and 2 to 90% of total hip replacements.[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] While most of the patients with HO remain asymptomatic, patients with large ossifications or concomitant femoroacetabular impingement can present stiffness and discomfort, for which surgical treatment is indicated.[1] [11] [12] [13]
HO etiology can be genetic such as the bone morphologic protein (BMP) dysregulation or nongenetic due to direct trauma or neurological injuries.[14] [15] The release of BMP in soft tissues can increase the tissue inflammatory response, which leads to modification in the biological cellular environment. Such tissular response triggers a misdifferentiation of the multipotent stem cells to osteoblasts and its consequent synthesis of ectopic tissue.[1] [15] [16]
Several risk factors for HO have been described including male gender, previous presence of HO, advanced age, anterolateral surgical approach, presence of cerebral or spine trauma, and hip arthritis.[1] [12] [13] Thus, the aim of this study is to describe the prevalence of HOs after hip arthroscopy in a series of patients with femoroacetabular impingement and to compare its preoperative and intraoperative variables with a matched control group of patients without HOs.
Methods
Study Design
This study was a retrospective analysis of a prospective case series with a case-control analysis of the preoperative and intraoperative variables of patients with and without HO after hip arthroscopy for femoroacetabular impingement.
Participants
From 2010 to 2017, all patients that required hip arthroscopy for femoroacetabular impingement were systematically included in a prospective database. Those who had a follow-up period more than 2 years were approached for eligibility.
All subjects conducted a baseline assessment consisting of the visual analog scale (VAS) for hip pain,[17] the modified Harris hip score (mHHS),[18] the hip outcome score (HOS),[19] and the international hip outcome test 33 (iHOT-33).[20] The assessments and a radiological control were repeated at 3, 6, 12, and 24 months after the surgery. Additionally, several intraoperative outcomes were recorded in the database including femoroacetabular impingement (FAI) morphology, which could be cam, pincer or mixed, presence of a labrum tear, treatment of labrum tear, and the acetabular labral articular disruption cartilage injury grade.
Radiographic exams were reviewed to obtain the number of patients with HO by the Brooker classification.[21] Cases were defined as Brooker grade ≥ I. For the case-control analysis, a control group was generated by randomly selecting 50 subjects with a Brooker grade = 0 matched by age and BMI to the case group. Preoperative and intraoperative variables from both groups were compared. All patients gave informed consent and allowed the authors to include their data in the prospective database.
Surgical Technique
Facilities, anesthetic and surgical team, postsurgical follow-up, and pharmacological guidelines were the same for all cases. The surgical procedure was performed using a classic approach. Three standard lateral, distal anterolateral, and anterior portals were used. Interportal capsulotomy was not performed routinely, as well as the vertical capsular approach, which was only performed in those cases in which a femoral osteoplasty was required. In all surgeries, the orbicular ligament was preserved. Once the traction was withdrawn and the hip was flexed at around 45 degrees, a femoral correction with rotations to control the anterior and posterior milling was performed. All surgeries ended without closing the articular capsule. Finally, subjects were instructed to follow a systematic prophylactic therapy to avoid deep venous thrombosis consisting of 10 days of low-molecular heparin and 50 mg of diclofenac every 8 hours for 14 days.
Statistical Analysis
Descriptive statistics were performed for all measurements. Normal distribution of the sample was analyzed using the Shapiro–Wilk test. In cases of normal distribution, chi-square tests and unpaired t-tests were used for qualitative and quantitative variables, respectively. In cases of nonnormal distribution, Fisher's exact test and Mann–Whitney U tests were used instead. The significance level was set at 0.05. All analyses were performed using SPSS Statistics (IBM Corp. Released 2011. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.).
Results
Between 2010 and 2017, 700 patients with hip arthroscopy for FAI were recorded in the database. From those, 15 (13 males, 2 females; 2.14%) presented radiological findings of HO. According to the Brooker classification, 10 patients had an HO grade I, one patient grade II, and four patients grade III ([Fig. 1]). None of the cases were associated with alterations in mobility, local pain, or required second surgery due to the ossification. The HOs were observed between 3- and 6-months after the surgery, with no progression in ossification noticed at 24-months.


A control group was randomly selected by choosing 50 subjects with a Brooker grade = 0 in their postoperative radiographic examinations matched to the case group by age and BMI. The characteristics of both groups are shown in [Table 1].
Abbreviation: BMI, body mass index.
No differences were observed in sex, age, BMI, or involved leg between groups (p > 0.05).
When comparing preoperative and intraoperative variables, the HO cases showed significant differences in the distribution of FAI morphology. The HO cases showed less cam morphology proportion than the control group (p = 0.022). Additionally, cases with HO showed higher rates of partial labrectomies and more severe cartilage injuries than the control group ([Table 2]). On the contrary, between-group differences were neither observed in preoperative pain or functional outcomes (VAS, HOS adl, HOS ss, mHHS, and iHOT-33) nor in the nature of labral injuries.
Heterotopic ossification (cases group) (n = 15) |
Control group (n = 50) |
p-Value |
|
---|---|---|---|
FAI morphology |
|||
Cam |
6 (40%) |
38 (76%) |
0.022 [a] |
Mixed |
7 (46.7%) |
10 (20%) |
|
Pincer |
2 (13.3%) |
2 (4%) |
|
Labrum injury |
|||
Labrum tear |
7 (46.7%) |
24 (48%) |
0.928 |
Chrondrolabral rupture |
8 (53.3%) |
26 (52%) |
|
Labrum treatment |
|||
Suture |
8 (53.3%) |
43 (86%) |
0.007 [a] |
Partial labrectomy |
7 (46.7%) |
7 (14%) |
|
ALAD |
|||
0 |
0 |
2 (4%) |
0.031 [a] |
1 |
2 (13.3%) |
16 (32%) |
|
2 |
1 (6.7%) |
9 (18%) |
|
3 |
3 (20%) |
15 (30%) |
|
4 |
4 (60%) |
8 (16%) |
|
VAS |
55.80 ± 18.27 |
58.64 ± 21.56 |
0.646 |
HOS adl |
76.59 ± 18.13 |
69.88 ± 19.74 |
0.245 |
HOS ss |
54.00 ± 27.79 |
44.11 ± 25.81 |
0.206 |
mHHS |
67.17 ± 16.19 |
71.65 ± 19.36 |
0.196 |
iHOT-33 |
38.17 ± 17.55 |
48.26 ± 23.58 |
0.141 |
Abbreviation: ALAD, acetabular labral articular disruption; FAI, femoroacetabular impingement; HOS, hip outcome score; HOS ADL, hip outcome scores in activities of daily living; HOS SS, hip outcome scores in sport scale; iHOT-33, international hip outcome test 33; mHHS, modified Harris hip score; VAS, visual analog scale.
Note: Bold means significant differences.
a Significance level < 0.05.
Discussion
This study showed an HO prevalence of 2.14% after hip arthroscopy in a series of patients with femoroacetabular impingement with 2-year follow-up. It also showed that those cases with HO had lower cam morphologies, higher rates of partial labrectomies, and more severe cartilage injuries. The same preoperative levels of hip pain and function were observed in the cases with and without HO.
HO has been a usual complication related to hip surgeries for years.[8] [9] [10] The grade of ossification is often described by Brooker classification which ranges from grade I, the appearance of woven bone in soft tissues, to a grade IV, complete articular ankylosis.
Previous studies have reported highly variable rates of HO after hip arthroscopy, some of them reaching up to an HO prevalence of 90%.[8] [9] [22] [23] Recently, lower prevalence rates have been reported according to miscellaneous articles.[24] [25] Even though the appearance of HO is highly variable,[2] the postoperative use of specific antiinflammatory medication such as celecoxib has been proved to reduce the number of HO cases,[26] with some case series describing an HO prevalence lower than 2 and 10%.[1] [2] [9] [25] [27] The rate of HO presented in this study is low compared with previous analysis. This fact could be explained by the surgical technique performed, with a special focus on the preservation of the access portals, with no interportal capsulotomies, with the complete preservation of the orbicular ligament, and without capsulotomy or vertical minimal capsulotomy. Another possible explanation for the lower ratios of HO reported in this study could be the systematic prescription of nonsteroidal anti-inflammatory drugs (NSAIDs) after the surgery. NSAIDs lead to an alteration in the osteoprogenitor cell, modifying the cellular environment and interfering with the tissue signals.[15] As results of such effect, NSAIDs have been included in several postoperative protocols with positive reported effects on HO formation.[11] [25] [26] [27] [28] [29] [30] [31] [32] Several studies have demonstrated that the use of NSAIDs diminishes the rate of HO after hip arthroscopy.[3] [4] [33] Bedi et al described an important HO rate decrease from 8.1 to 1.8% with the systematic use of NSAIDs,[11] similar to the results showed by Randelli et al, with a notable decrease from 33 to 0% after the prophylactic use of NSAIDs for 3 weeks after the arthroscopic surgery.[25] However, there is a concern regarding the use of NSAIDs due to their intrinsic side effects, especially in older patients, that can cause gastrointestinal problems, bleedings or renal alterations, and blood pressure modifications.[27] In those cases, alternative preventive therapies such as low doses of radiotherapy may be useful, as they have been proved as a valid method for reducing HO rates, although at higher economic costs.[12] [26]
Risk factors for HOs have been widely described after total hip arthroplasties, but less attention has been given to the risk factors of HO after hip arthroscopy.[2] [5] [6] [7] Randelli et al observed a relationship between HO and capsular incision, the excess of bone resection, the location of labral approaches, and male gender.[25] Bedi et al described male gender and osteochondroplasty performance as risk factors for HO.[11] On the contrary, Rath et al and Amar et al reported contradictory results in capsular closing as a risk factor for HO appearance.[29] [34] In the current study, those HO cases reported more severe cartilage injuries and less cam morphology proportion than the control group with no HO. Additionally, HO cases presented higher rates of partial labrectomies compared with the control group in which more labral sutures were performed. Our results suggest that those patients with more severe injury grades may require associated surgical procedures that could damage the surrounding soft tissues and promote ossifications. It is known that aggressive handling during hip arthroplasties produces higher injury rates.[2] [9] Further studies should investigate the relation between the number of surgical actions required, injury severity, and the appearance of HOs in larger samples with more HO cases.
This study has some limitations. First, the relation between NSAIDs use and HO rate was not studied as in the current case series all subjects underwent a postoperative prophylactic treatment that included NSAIDs for 14 days. The same limitation happened regarding the surgical technique, all subjects were operated by the same medical and anesthetic team which, although increasing the between-group homogeneity, does not allowed us to study the relation between surgical actions and HO rates.
Conclusions
HOs were found in 2.14% of the subjects after hip arthroscopy for femoroacetabular impingement and 14 days of NSAIDs prophylactic protocol. HO cases had more severe cartilage injuries, lower proportion of cam morphologies, and higher rates of partial labrectomies compared with controls without HO.
Conflict of Interests
None declared.
Ethical Review
The present study was reviewed and approved by the Ethical Committee at Hospital, Quirón, Barcelona.
-
References
- 1 Amar E, Sharfman ZT, Rath E. Heterotopic ossification after hip arthroscopy. J Hip Preserv Surg 2015; 2 (04) 355-363
- 2 Rath E, Sherman H, Sampson TG, Ben Tov T, Maman E, Amar E. The incidence of heterotopic ossification in hip arthroscopy. Arthroscopy 2013; 29 (03) 427-433
- 3 Arshad Z, Maughan HD, Garner M, Ali E, Khanduja V. Incidence of heterotopic ossification following hip arthroscopy is low: considerations for routine prophylaxis. Int Orthop 2022; 46 (07) 1489-1500
- 4 Zhou L, Gee SM, Hansen JA, Posner MA. Heterotopic ossification after arthroscopic procedures: a scoping review of the literature. Orthop J Sport Med 2022; 10 (01) 23 259671211060040
- 5 Bozic KJ, Chan V, Valone III FH, Feeley BT, Vail TP. Trends in hip arthroscopy utilization in the United States. J Arthroplasty 2013; 28 (8, Suppl): 140-143
- 6 Degen RM, Bernard JA, Pan TJ. et al. Hip arthroscopy utilization and associated complications: a population-based analysis. J Hip Preserv Surg 2017; 4 (03) 240-249
- 7 Maradit Kremers H, Schilz SR, Van Houten HK. et al. Trends in utilization and outcomes of hip arthroscopy in the United States between 2005 and 2013. J Arthroplasty 2017; 32 (03) 750-755
- 8 Charnley J. The long-term results of low-friction a primary arthroplasty intervention. J Bone Joint Surg Br 1972; 54-B: 61-76
- 9 Gao GY, Zhang X, Dai LH. et al. Heterotopic ossification after arthroscopy for hip impingement syndrome. Chin Med J (Engl) 2019; 132 (07) 827-833
- 10
Kan SL,
Yang B,
Ning GZ.
et al.
Nonsteroidal anti-inflammatory drugs as prophylaxis for heterotopic ossification after
total hip arthroplasty. Medicine (Baltimore) 2015; 94 (18) e828
Reference Ris Wihthout Link
- 11 Bedi A, Zbeda RM, Bueno VF, Downie B, Dolan M, Kelly BT. The incidence of heterotopic ossification after hip arthroscopy. Am J Sports Med 2012; 40 (04) 854-863
- 12 Milakovic M, Popovic M, Raman S, Tsao M, Lam H, Chow E. Radiotherapy for the prophylaxis of heterotopic ossification: a systematic review and meta-analysis of randomized controlled trials. Radiother Oncol 2015; 116 (01) 4-9
- 13 Newman EA, Holst DC, Bracey DN, Russell GB, Lang JE. Incidence of heterotopic ossification in direct anterior vs posterior approach to total hip arthroplasty: a retrospective radiographic review. Int Orthop 2016; 40 (09) 1967-1973
- 14
Firoozabadi R,
Alton T,
Sagi HC.
Heterotopic ossification in acetabular fracture surgery. J Am Acad Orthop Surg 2017;
25 (02) 117-124
Reference Ris Wihthout Link
- 15 Hoyt BW, Pavey GJ, Potter BK, Forsberg JA. Heterotopic ossification and lessons learned from fifteen years at war: a review of therapy, novel research, and future directions for military and civilian orthopaedic trauma. Bone 2018; 109 (109) 3-11
- 16 Winkler S, Craiovan B, Wagner F, Weber M, Grifka J, Renkawitz T. Pathogenesis and prevention strategies of heterotopic ossification in total hip arthroplasty: a narrative literature review and results of a survey in Germany. Arch Orthop Trauma Surg 2015; 135 (04) 481-489
- 17 Langley GB, Sheppeard H. The visual analogue scale: its use in pain measurement. Rheumatol Int 1985; 5 (04) 145-148
- 18 Navarro M, Ruiz L, Hervás M, Peiró S, Payá A. Validez de la escala de cadera de Harris en la Rehabilitación tras artroplastia de cadera. Rehabilitacion (Madr) 2005; 39 (04) 147-154
- 19 Seijas R, Sallent A, Ruiz-Ibán MA. et al. Validation of the Spanish version of the Hip Outcome Score: a multicenter study. Health Qual Life Outcomes 2014; 12 (12) 70
- 20 Ruiz-Ibán MA, Seijas R, Sallent A. et al. The international Hip Outcome Tool-33 (iHOT-33): multicenter validation and translation to Spanish. Health Qual Life Outcomes 2015; 13 (13) 62
- 21
Brooker AF,
Bowerman JW,
Robinson RA,
Riley Jr LH.
Ectopic ossification following total hip replacement. Incidence and a method of classification.
J Bone Joint Surg Am 1973; 55 (08) 1629-1632
Reference Ris Wihthout Link
- 22 Banaszkiewicz PA, Kader DF. Classic Papers in Orthopaedics. 2014: 1-624
- 23 Clohisy JC, Zebala LP, Nepple JJ, Pashos G. Combined hip arthroscopy and limited open osteochondroplasty for anterior femoroacetabular impingement. J Bone Joint Surg Am 2010; 92 (08) 1697-1706
- 24 Byrd JWT, Jones KS. Arthroscopic femoroplasty in the management of cam-type femoroacetabular impingement. Clin Orthop Relat Res 2009; 467 (03) 739-746
- 25 Randelli F, Pierannunzii L, Banci L, Ragone V, Aliprandi A, Buly R. Heterotopic ossifications after arthroscopic management of femoroacetabular impingement: the role of NSAID prophylaxis. J Orthop Traumatol 2010; 11 (04) 245-250
- 26 Dow T, King JP, Wong IH. The reduction of heterotopic ossification incidence after hip arthroscopy in patients treated with selective cyclooxygenase 2 inhibitor (Celecoxib). Arthroscopy 2020; 36 (02) 453-461
- 27 Beckmann JT, Wylie JD, Kapron AL, Hanson JA, Maak TG, Aoki SK. The effect of NSAID prophylaxis and operative variables on heterotopic ossification after hip arthroscopy. Am J Sports Med 2014; 42 (06) 1359-1364
- 28 Beckmann JT, Wylie JD, Potter MQ, Maak TG, Greene TH, Aoki SK. Effect of Naproxen on HO following hip arthroscopy. J Bone Joint Surg Am 2015; 97 (24) 2032-2037
- 29 Rath E, Warschawski Y, Maman E. et al. Selective COX-2 inhibitors significantly reduce the occurrence of heterotopic ossification after hip arthroscopic surgery. Am J Sports Med 2016; 44 (03) 677-681
- 30 Nissen SE, Yeomans ND, Solomon DH. et al; PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016; 375 (26) 2519-2529
- 31 Patrono C, Baigent C. Coxibs, traditional NSAIDs, and cardiovascular safety post-PRECISION: what we thought we knew then and what we think we know now. Clin Pharmacol Ther 2017; 102 (02) 238-245
- 32
Zhu XT,
Chen L,
Lin JH.
Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention
of heterotopic ossification after total hip arthroplasty: a meta-analysis. Medicine
(Baltimore) 2018; 97 (31) e11649
Reference Ris Wihthout Link
- 33 Schaver AL, Willey MC, Westermann RW. Incidence of heterotopic ossification with NSAID prophylaxis is low after open and arthroscopic hip preservation surgery. Arthrosc Sports Med Rehabil 2021; 3 (05) e1309-e1314
- 34 Amar E, Warschawski Y, Sampson TG, Atoun E, Steinberg EL, Rath E. Capsular closure does not affect development of heterotopic ossification after hip arthroscopy. Arthroscopy 2015; 31 (02) 225-230
Address for correspondence
Publication History
Received: 28 March 2021
Accepted: 22 September 2022
Article published online:
06 February 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Amar E, Sharfman ZT, Rath E. Heterotopic ossification after hip arthroscopy. J Hip Preserv Surg 2015; 2 (04) 355-363
- 2 Rath E, Sherman H, Sampson TG, Ben Tov T, Maman E, Amar E. The incidence of heterotopic ossification in hip arthroscopy. Arthroscopy 2013; 29 (03) 427-433
- 3 Arshad Z, Maughan HD, Garner M, Ali E, Khanduja V. Incidence of heterotopic ossification following hip arthroscopy is low: considerations for routine prophylaxis. Int Orthop 2022; 46 (07) 1489-1500
- 4 Zhou L, Gee SM, Hansen JA, Posner MA. Heterotopic ossification after arthroscopic procedures: a scoping review of the literature. Orthop J Sport Med 2022; 10 (01) 23 259671211060040
- 5 Bozic KJ, Chan V, Valone III FH, Feeley BT, Vail TP. Trends in hip arthroscopy utilization in the United States. J Arthroplasty 2013; 28 (8, Suppl): 140-143
- 6 Degen RM, Bernard JA, Pan TJ. et al. Hip arthroscopy utilization and associated complications: a population-based analysis. J Hip Preserv Surg 2017; 4 (03) 240-249
- 7 Maradit Kremers H, Schilz SR, Van Houten HK. et al. Trends in utilization and outcomes of hip arthroscopy in the United States between 2005 and 2013. J Arthroplasty 2017; 32 (03) 750-755
- 8 Charnley J. The long-term results of low-friction a primary arthroplasty intervention. J Bone Joint Surg Br 1972; 54-B: 61-76
- 9 Gao GY, Zhang X, Dai LH. et al. Heterotopic ossification after arthroscopy for hip impingement syndrome. Chin Med J (Engl) 2019; 132 (07) 827-833
- 10
Kan SL,
Yang B,
Ning GZ.
et al.
Nonsteroidal anti-inflammatory drugs as prophylaxis for heterotopic ossification after
total hip arthroplasty. Medicine (Baltimore) 2015; 94 (18) e828
Reference Ris Wihthout Link
- 11 Bedi A, Zbeda RM, Bueno VF, Downie B, Dolan M, Kelly BT. The incidence of heterotopic ossification after hip arthroscopy. Am J Sports Med 2012; 40 (04) 854-863
- 12 Milakovic M, Popovic M, Raman S, Tsao M, Lam H, Chow E. Radiotherapy for the prophylaxis of heterotopic ossification: a systematic review and meta-analysis of randomized controlled trials. Radiother Oncol 2015; 116 (01) 4-9
- 13 Newman EA, Holst DC, Bracey DN, Russell GB, Lang JE. Incidence of heterotopic ossification in direct anterior vs posterior approach to total hip arthroplasty: a retrospective radiographic review. Int Orthop 2016; 40 (09) 1967-1973
- 14
Firoozabadi R,
Alton T,
Sagi HC.
Heterotopic ossification in acetabular fracture surgery. J Am Acad Orthop Surg 2017;
25 (02) 117-124
Reference Ris Wihthout Link
- 15 Hoyt BW, Pavey GJ, Potter BK, Forsberg JA. Heterotopic ossification and lessons learned from fifteen years at war: a review of therapy, novel research, and future directions for military and civilian orthopaedic trauma. Bone 2018; 109 (109) 3-11
- 16 Winkler S, Craiovan B, Wagner F, Weber M, Grifka J, Renkawitz T. Pathogenesis and prevention strategies of heterotopic ossification in total hip arthroplasty: a narrative literature review and results of a survey in Germany. Arch Orthop Trauma Surg 2015; 135 (04) 481-489
- 17 Langley GB, Sheppeard H. The visual analogue scale: its use in pain measurement. Rheumatol Int 1985; 5 (04) 145-148
- 18 Navarro M, Ruiz L, Hervás M, Peiró S, Payá A. Validez de la escala de cadera de Harris en la Rehabilitación tras artroplastia de cadera. Rehabilitacion (Madr) 2005; 39 (04) 147-154
- 19 Seijas R, Sallent A, Ruiz-Ibán MA. et al. Validation of the Spanish version of the Hip Outcome Score: a multicenter study. Health Qual Life Outcomes 2014; 12 (12) 70
- 20 Ruiz-Ibán MA, Seijas R, Sallent A. et al. The international Hip Outcome Tool-33 (iHOT-33): multicenter validation and translation to Spanish. Health Qual Life Outcomes 2015; 13 (13) 62
- 21
Brooker AF,
Bowerman JW,
Robinson RA,
Riley Jr LH.
Ectopic ossification following total hip replacement. Incidence and a method of classification.
J Bone Joint Surg Am 1973; 55 (08) 1629-1632
Reference Ris Wihthout Link
- 22 Banaszkiewicz PA, Kader DF. Classic Papers in Orthopaedics. 2014: 1-624
- 23 Clohisy JC, Zebala LP, Nepple JJ, Pashos G. Combined hip arthroscopy and limited open osteochondroplasty for anterior femoroacetabular impingement. J Bone Joint Surg Am 2010; 92 (08) 1697-1706
- 24 Byrd JWT, Jones KS. Arthroscopic femoroplasty in the management of cam-type femoroacetabular impingement. Clin Orthop Relat Res 2009; 467 (03) 739-746
- 25 Randelli F, Pierannunzii L, Banci L, Ragone V, Aliprandi A, Buly R. Heterotopic ossifications after arthroscopic management of femoroacetabular impingement: the role of NSAID prophylaxis. J Orthop Traumatol 2010; 11 (04) 245-250
- 26 Dow T, King JP, Wong IH. The reduction of heterotopic ossification incidence after hip arthroscopy in patients treated with selective cyclooxygenase 2 inhibitor (Celecoxib). Arthroscopy 2020; 36 (02) 453-461
- 27 Beckmann JT, Wylie JD, Kapron AL, Hanson JA, Maak TG, Aoki SK. The effect of NSAID prophylaxis and operative variables on heterotopic ossification after hip arthroscopy. Am J Sports Med 2014; 42 (06) 1359-1364
- 28 Beckmann JT, Wylie JD, Potter MQ, Maak TG, Greene TH, Aoki SK. Effect of Naproxen on HO following hip arthroscopy. J Bone Joint Surg Am 2015; 97 (24) 2032-2037
- 29 Rath E, Warschawski Y, Maman E. et al. Selective COX-2 inhibitors significantly reduce the occurrence of heterotopic ossification after hip arthroscopic surgery. Am J Sports Med 2016; 44 (03) 677-681
- 30 Nissen SE, Yeomans ND, Solomon DH. et al; PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016; 375 (26) 2519-2529
- 31 Patrono C, Baigent C. Coxibs, traditional NSAIDs, and cardiovascular safety post-PRECISION: what we thought we knew then and what we think we know now. Clin Pharmacol Ther 2017; 102 (02) 238-245
- 32
Zhu XT,
Chen L,
Lin JH.
Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention
of heterotopic ossification after total hip arthroplasty: a meta-analysis. Medicine
(Baltimore) 2018; 97 (31) e11649
Reference Ris Wihthout Link
- 33 Schaver AL, Willey MC, Westermann RW. Incidence of heterotopic ossification with NSAID prophylaxis is low after open and arthroscopic hip preservation surgery. Arthrosc Sports Med Rehabil 2021; 3 (05) e1309-e1314
- 34 Amar E, Warschawski Y, Sampson TG, Atoun E, Steinberg EL, Rath E. Capsular closure does not affect development of heterotopic ossification after hip arthroscopy. Arthroscopy 2015; 31 (02) 225-230

